Aptevo annual meeting: both director nominees elected, all four proposals approved

Aptevo Therapeutics Inc.

Zs. Harsanyi re-elected director: 216,997 for, 17,454 withheld; Barbara Lopez Kunz: 211,050 for, 23,401 withheld.
Ratification of Baker Tilly US LLP as 2026 auditor: 606,661 for, 28,847 against, 1,370 abstain.
Advisory vote on 2025 executive compensation approved: 165,615 for, 24,031 against, 44,805 abstain.
Fourth Amended and Restated 2018 Stock Incentive Plan approved: 166,484 for, 64,248 against, 3,719 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.